JUDY SCHULZ: Open Payments
NPI 1255781126 · KENNESAW, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,225 in 52 payments from 14 companies in 2025. Trend: 2023 $1,722 · 2024 $1,687 · 2025 $1,225
Food & beverage: $1,225
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $217 |
| PFIZER INC. | 9 | $194 |
| Astellas Pharma US Inc | 3 | $170 |
| AstraZeneca Pharmaceuticals LP | 5 | $169 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $94 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| Actelion Pharmaceuticals US, Inc. | 3 | $56 |
| HEARTFLOW, INC. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
Products named: Veozah, WAINUA, ELIQUIS, WINREVAIR, LEQVIO, VERQUVO, VYNDAQEL, LifeVest.
Industry payments across GA — which companies pay providers there.
